Epidemiology Practice Questions

Q: Which of the following is NOT a condition in which healthy carriers are commonly found?

Typhoid. **Explanation** The core concept tested here is the classification of carriers based on their clinical state. A **Healthy Carrier** is an individual who harbors the pathogen but has never suffered from the clinical disease (subclinical infection). In contrast, a **Chronic Carrier** is someone who continues to harbor the pathogen for months or years *following* an attack of the disease. **1. Why Typhoid is the correct answer:** In **Typhoid (Enteric fever)**, carriers are almost exclusively **convalescent** or **chronic carriers**. They harbor *Salmonella typhi* in the gallbladder or biliary tract (or urinary tract) following a clinical bout of the disease. While subclinical infections occur, the classic "carrier state" associated with Typhoid (like the famous Mary Mallon) follows a clinical infection, making "Healthy Carrier" an inappropriate classification for the primary epidemiological reservoir of Typhoid. **2. Analysis of Incorrect Options:** * **Cholera:** Healthy carriers (subclinical cases) are very common. In *Vibrio cholerae* (especially El Tor), the ratio of healthy carriers to clinical cases can be as high as 50:1 to 100:1. * **Diphtheria:** Healthy carriers are the primary reservoir for *Corynebacterium diphtheriae*. They outnumber clinical cases and are crucial for the continued transmission of the bacteria in the community. * **Pertussis:** While less common than in Diphtheria, healthy (asymptomatic) carriers do exist and contribute to the transmission of *Bordetella pertussis*, especially in immunized populations where the infection may not manifest clinically. **High-Yield Clinical Pearls for NEET-PG:** * **Typhoid:** The chronic carrier state is more common in **females** and those with **gallstones**. * **Measles:** Does **NOT** have a carrier state (only clinical cases). * **Incubatory Carriers:** Seen in Measles, Mumps, Polio, and Hepatitis B. * **Convalescent Carriers:** Seen in Typhoid, Dysentery, and Pertussis.

Q: Herd immunity is not observed in which of the following diseases?

Tetanus. ### Explanation **Concept of Herd Immunity** Herd immunity (community immunity) refers to the indirect protection from an infectious disease that happens when a large percentage of a population becomes immune, thereby reducing the overall amount of virus or bacteria able to spread. For herd immunity to occur, the disease **must be transmitted from person to person.** **Why Tetanus is the Correct Answer** Tetanus is caused by *Clostridium tetani* spores found in the soil and environment. The infection is acquired through direct contact with contaminated wounds, not through human-to-human transmission. Since an immune individual cannot "break the chain of transmission" to protect an unvaccinated neighbor, **herd immunity does not exist for Tetanus.** Protection is purely individual and depends entirely on one's own vaccination status. **Analysis of Incorrect Options** * **Poliomyelitis:** Transmitted via the feco-oral route. Mass vaccination (especially with OPV) induces intestinal immunity, reducing the shedding of the virus in the community and protecting the unvaccinated. * **Measles:** Highly contagious via respiratory droplets. It requires a very high herd immunity threshold (approx. 94-95%) to stop outbreaks. * **Diphtheria:** Transmitted via respiratory droplets. Vaccination with the Diphtheria toxoid reduces the carrier state and limits the spread of *Corynebacterium diphtheriae* within a population. **High-Yield Clinical Pearls for NEET-PG** * **Herd Immunity Threshold:** The proportion of immune individuals in a population above which a disease no longer persists. It is calculated as $1 - (1/R_0)$. * **Prerequisite:** Herd immunity only applies to diseases where the **only reservoir is humans.** * **Tetanus Fact:** It is the only vaccine-preventable disease that is **infectious but not contagious.** * **Eradication:** Herd immunity is a key factor in the successful eradication of Smallpox and the near-eradication of Polio.

Q: All of the following are true of the standardized mortality ratio except:

Expressed as a rate per rate. **Standardized Mortality Ratio (SMR)** is a key tool in epidemiology used for **indirect standardization**. It is primarily used when age-specific death rates for the study population are unknown or the population size is too small to provide stable rates. ### Why Option A is the Correct Answer (The Exception) The SMR is a **ratio**, not a rate. It is expressed as a **percentage** (or a decimal), calculated by dividing the observed deaths by the expected deaths. A "rate" typically has a time dimension and a multiplier (like per 1,000), whereas SMR compares two quantities to see if the observed count deviates from the norm. Therefore, saying it is a "rate per rate" is mathematically incorrect. ### Explanation of Other Options * **Option B (Can be adjusted for age):** This is true. SMR is the hallmark of indirect standardization, used specifically to account for (adjust) age distribution differences between a study group (e.g., miners) and the general population. * **Option C (Can be used for events other than death):** This is true. The same mathematical principle can be applied to calculate the **Standardized Incidence Ratio (SIR)** for diseases or hospital admissions. * **Option D (Ratio of observed deaths to expected deaths):** This is the fundamental definition of SMR. * *Formula:* $\text{SMR} = \frac{\text{Observed Deaths}}{\text{Expected Deaths}} \times 100$ ### High-Yield NEET-PG Pearls * **Interpretation:** An SMR of **100** means observed deaths equal expected deaths. An SMR of **150** means mortality is 50% higher than expected. * **Direct vs. Indirect:** Use **Direct Standardization** if age-specific death rates of the study population are *known*. Use **Indirect (SMR)** if they are *unknown*. * **Standard Population:** In SMR, the "Expected Deaths" are calculated by applying the age-specific death rates of a **standard population** to the age structure of the **study population**.

Q: In a population of 5000, there are 500 new cases of TB and 150 old cases. What is the prevalence of TB?

13%. ### Explanation **1. Why Option C is Correct** Prevalence refers to the total number of individuals in a population who have a disease at a specific point in time (Point Prevalence) or during a specified period (Period Prevalence). The formula for prevalence is: **Prevalence = (All existing cases [New + Old] / Total Population) × 100** In this scenario: * New cases = 500 * Old cases = 150 * Total existing cases = 500 + 150 = 650 * Total population = 5000 **Calculation:** (650 / 5000) × 100 = **13%**. **2. Why Other Options are Incorrect** * **Option A (9%):** This value is obtained if you only calculate the prevalence of old cases (450/5000) or make a calculation error. * **Option B (12%):** This is an incorrect calculation. * **Option D (18%):** This value is obtained if the denominator is incorrectly reduced or if numbers are misapplied. Note that **10%** (500/5000) would represent the **Incidence**, which only accounts for new cases. **3. NEET-PG High-Yield Pearls** * **Incidence vs. Prevalence:** Incidence measures the rate of occurrence of *new* cases (useful for acute diseases/etiology), while Prevalence measures the *burden* of the disease (useful for chronic diseases/health planning). * **The Relationship Formula:** Prevalence (P) = Incidence (I) × Mean Duration of disease (D). * **Factors Increasing Prevalence:** Longer duration of disease, prolongation of life without a cure, increase in new cases (incidence), and in-migration of cases. * **Factors Decreasing Prevalence:** Shorter duration of disease, high case fatality rate, and improved cure rates.

Q: The time required for the development of a parasite from the gametocyte to the sporozoite stage in a mosquito is called as:

Extrinsic incubation period. ### Explanation **Correct Answer: A. Extrinsic incubation period** The **Extrinsic Incubation Period (EIP)** is the time interval required for a pathogen to develop or multiply within an arthropod vector (like a mosquito) before it becomes infective to a vertebrate host. In the context of Malaria, this represents the duration from the ingestion of **gametocytes** by the mosquito to the appearance of **sporozoites** in its salivary glands. This period is highly temperature-dependent; for *Plasmodium vivax*, it is approximately 8–10 days at 25°C. **Analysis of Incorrect Options:** * **B. Intrinsic incubation period:** This is the time interval between the entry of the pathogen into the **human host** and the onset of the first clinical sign or symptom. * **C. Generation time:** This refers to the interval between the receipt of infection by a host and the maximum infectivity of that host. In malaria, it is the time from the entry of sporozoites into a human until the peak production of gametocytes. * **D. Median incubation period:** This is a statistical measure representing the time required for 50% of an exposed population to develop the disease. **High-Yield Facts for NEET-PG:** * **Serial Interval:** The time gap between the onset of the primary case and the onset of the secondary case in a transmission chain. * **Pre-patent Period:** The time between the entry of the parasite and its first demonstration in the blood or excreta (e.g., 8 days for *P. falciparum*). * **Environmental Impact:** If the extrinsic incubation period exceeds the lifespan of the mosquito, transmission of the disease cannot occur. This is a key principle in vector control strategies.

Question 1

Which of the following is NOT a condition in which healthy carriers are commonly found?

Accepted Answer

Typhoid

Answer

Cholera

Answer

Diphtheria

Answer

Pertussis

Question 2

Which of the following is NOT a primordial prevention strategy?

Accepted Answer

Screening for hypertension

Answer

Exercise

Answer

Good nutrition

Answer

No smoking

Question 3

Herd immunity is not observed in which of the following diseases?

Accepted Answer

Tetanus

Answer

Poliomyelitis

Answer

Measles

Answer

Diphtheria

Question 4

Lifestyle modification, specifically discouraging children from adopting harmful lifestyles, is considered which level of prevention?

Accepted Answer

Primordial prevention

Answer

Primary level of prevention

Answer

Secondary level of prevention

Answer

Tertiary level of prevention

Question 5

All of the following are true of the standardized mortality ratio except:

Accepted Answer

Expressed as a rate per rate

Answer

Can be adjusted for age

Answer

Can be used for events other than death

Answer

Ratio of observed deaths to expected deaths

Question 6

Confounding factors can be eliminated by:

Accepted Answer

Matching

Answer

Correlation

Answer

Standardization

Answer

Randomization

Question 7

In which type of study is the 'group' considered the unit of study?

Accepted Answer

Cluster randomized controlled trial

Answer

Ecological study

Answer

Cross-sectional study

Answer

Randomized controlled trial

Question 8

In a population of 5000, there are 500 new cases of TB and 150 old cases. What is the prevalence of TB?

Accepted Answer

13%

Answer

9%

Answer

12%

Answer

18%

Question 9

The time required for the development of a parasite from the gametocyte to the sporozoite stage in a mosquito is called as:

Accepted Answer

Extrinsic incubation period

Answer

Intrinsic incubation period

Answer

Generation time

Answer

Median incubation period

Question 10

Herd immunity is a feature of which of the following diseases?

Accepted Answer

Tetanus

Answer

Diphtheria

Answer

Polio

Answer

Measles

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?